Day-Blooming Jessamine Poisoning (Enzootic Calcinosis) in Horses
Key takeaways
Day-blooming jessamine poisoning is a life-threatening condition caused by the ingestion of day blooming jessamine (Cestrum diurnum), a plant high in calcitriol.
- Ingestion of a toxic dose of C. diurnum causes a condition in horses called enzootic calcinosis, where soft tissues become hardened due to build up of calcium
- Symptoms include gait changes, weakness, weight loss, and recumbency
- Diagnosis is based on physical examination, diagnostic imaging, history of exposure, and blood tests
- There is no treatment for enzootic calcinosis, and once the soft tissues calcify, there is no way of reversing the mineralization
- Due to the absence of treatment options, prevention is of the utmost importance
- Providing adequate amounts of alternative forage decreases the chances of animals grazing on infested pastures
Connect with a vet to get more information about your pet’s health.
A closer look: Day-Blooming Jessamine Poisoning (Enzootic Calcinosis) in Horses
Day-blooming jessamine is native to the West Indies and is cultivated widely throughout India and South Asia. This plant produces a substance called calcitriol. If a horse ingests a sufficient quantity of calcitriol, the normal process of calcium excretion is interrupted, leading to build up of calcium deposits in soft tissues.
Calcium is a mineral used by the body for proper muscle function. As muscles work, calcium is normally excreted into the bloodstream and replenished. If this process is interrupted, calcium builds up in the muscle tissue, causing the tissue to become hardened or mineralized. In severe cases, mineralization can disrupt or even prevent normal muscle function.
Calcification of muscle tissue is irreversible. The only way to ensure horses do not develop enzootic calcinosis is to prevent grazing on calcitriol-containing plants.
Risk factors
Day-blooming jessamine toxicosis is uncommon in horses. Enzootic calcinosis is a life-threatening condition that causes the calcification of the vital organs. There is no treatment for tissue mineralization, and soft-tissue calcification is not reversible.
Animals with insufficient access to alternative sources of forage are more likely to graze on calcitriol-containing plants.
Possible causes
Enzootic calcinosis is caused by the ingestion of calcitriol-containing plants, primarily day-blooming jessamine (Cestrum diurnum).
Calcitriol is the active form of vitamin D. Once ingested, excess calcitriol increases absorption of calcium and reduces its excretion. The calcium accumulates in the tissues, leading to soft-tissue calcification.
Main symptoms
Testing and diagnosis
Early diagnosis of enzootic calcinosis can be difficult. Horses exhibiting symptoms of day-blooming jessamine toxicosis generally undergo the following diagnostics:
- Physical examination
- Blood tests
- Diagnostic imaging: x-rays and ultrasounds are used to determine the presence of calcium deposits
Steps to Recovery
There is no specific treatment for enzootic calcinosis, and soft-tissue calcification is not reversible. The only treatment options are:
- Stopping use of infested pasture
- Discontinuing any ongoing vitamin D supplementation
- Pain relief medications
- IV fluids to promote calcium excretion
As there is no available treatment, enzootic calcinosis generally carries a poor prognosis.
Surviving animals are likely to suffer from chronic poor performance.
Horses removed from infested pastures before the onset of soft tissue calcification carry a good prognosis.
Prevention
Day-blooming jessamine toxicosis is not contagious.
The absence of treatment for enzootic calcinosis makes prevention of the utmost importance. Prevention strategies include:
- Change of pasture to prevent access to the plant
- Eradication and destruction of calcitriol-containing plants
- Providing a sufficient amount of alternative forage such as hay or grass pasture
Is Day-Blooming Jessamine Poisoning (Enzootic Calcinosis) in Horses common?
Day-blooming jessamine toxicosis is uncommon in horses.
Typical Treatment
- Supportive care
- Discontinuation of Vitamin D supplementation